Appointments News in Brief – a new Director of Research and Development at OUH, new Chief Operating Officer for Royal Surrey

Our brand new appointments round-up is here, where we highlight the latest appointments to new roles from across the world of health and care!

Today’s edition features a new appointment of a Director of Research and Development at Oxford University Hospitals, two Co-Deputy Clinical Directors for Research at Liverpool University Hospitals, and a new Chief Operating officer for Royal Surrey FT, plus much more.

Oxford University Hospitals appoints new Director of Research and Development

Oxford University Hospitals has appointed Professor Adrian Banning as its new Director of Research and Development. 

Professor Banning, Consultant Cardiologist, has been chosen for the role and will replace Professor Keith Channon, who has been appointed as Head of the University of the Oxford’s Radcliffe Department of Medicine. 

Bringing a wealth of experience to the role, Professor Banning has previously worked as Lead Clinician for the Thames Valley Cardiac Clinical Network, Lead Clinician for South Central Cardiac Cardiovascular Research, Clinical Director and Divisional Director at OUH, and a Co-theme Lead for the Oxford Biomedical Research Centre’s Cardiac theme. 

Prof Meghana Pandit, Chief Executive Officer, OUH, commented on the new appointment: “I’d like to welcome Adrian to what is a key role not just for research in our Trust but for the Oxford healthcare research partnership.

“With his distinguished clinical and research track record, I’m sure he will be the right person to build on the great work Keith has done to keep Oxford as a world-leading centre for medical research.” 

LUHFT appoints two new Co-Deputy Clinical Directors for Research

Liverpool University Hospitals NHS Foundation Trust has appointed two new Co-Deputy Clinical Directors for Research. 

Dr Terry McLoughlin, A&E Consultant, and Dr Emily Clarke, Consultant in Genitourinary Medicine and HIV, have been chosen for the role, following their completion of the Research Scholars Programme – a two-year training programme run by the Clinical Research Network; North West Coast (CRN NWC). 

Dr McLoughlin commented on her new appointment: “This is a brand-new role and, together with Dr Clarke, we want to support the directorate, engage more staff and ultimately increase the research output of what is one of the largest NHS Trusts in the country.”

Dr Clarke, who is now also the Associate Clinical Director of the Research Scholars Programme, said “I am really excited to take up my new role. Research is important for delivering good patient care and by expanding our research offer to patients we can bring new treatments and investigations to them.” 

Royal Surrey FT appoints new Chief Operating Officer

Royal Surrey NHS Foundation Trust has appointed a new Chief Operating Officer.  

After a competitive recruitment process, Matt Jarratt, Associate Director of Operations (ADO) for Access & Medicine and Community, has been chosen for the role.  

Having an extensive career in NHS operational management, Matt has served as Royal Surrey’s ADO for Access and Medicine since June 2019.  

As well as acquiring significant experience within the acute setting, Matt has also held a position at Board level at CSH Surrey, the North West Surrey community service provider.  

Louise Stead, Chief Executive, Royal Surrey NHS FT, said: “The Chief Operating Officer role is absolutely crucial to the smooth running of the Trust, particularly in the context of Covid and the operational challenges that come with it. Matt has a wealth of experience in operational management, including at Board level – I know he will continue driving us forward to do the very best for our patients.” 

The Princess Alexandria Hospital appoints new non-executive Director

The Princess Alexandria Hospital NHS Trust has appointed a new associate non-executive Director.  

Dr Rob Gerlis, who has served as a GP for over 30 years, has been chosen for the role.  

Acquiring a plethora of experience within Board-level roles, Rob has worked as the Chair of West Essex Clinical Commissioning Group for nine years and has taken on the role of chair of Stellar Healthcare – a GP provider company covering Harlow and Epping Forest. 

Commenting on his new appointment, Dr Gerlis said: “I am excited to have joined the PAHT board – this is a fantastic opportunity to make a difference to the community. I am looking forward to working with colleagues to create a modern, integrated local health and care system.” 

Hattie Llewelyn-Davies, chair of The Princess Alexandra Hospital NHS Trust, said: “I warmly welcome Rob to our board – he has a wealth of experience that will greatly benefit our organisation. I am delighted that he will be supporting us to develop and improve our hospitals for our patients and our people into the future.” 

Hertfordshire Community has appointed a new permanent Chief Executive Officer

Hertfordshire Community NHS Trust has appointed a new permanent Chief Executive Officer.  

Elliot Jones, who has served as interim CEO as the trust since 2020, has been chosen for the role.  

Previously serving as the Director of Performance and Improvement in the NHS England East of England, Elliot led the operational response and strategic planning for the COVID-19 pandemic across the region.  

Elliot said of his new appointment: “HCT is a fantastic organisation delivering in excess of 50,000 appointments in people’s homes and clinics every month. It delivers a fantastic service to the people of Hertfordshire through the dedication and talent of colleagues throughout the organisation.”  

“Much of the focus during the past year has been on our COVID response and delivery. However, I feel we are now entering a new phase where we can focus more on the delivery on our plans for healthier communities and outstanding services.”